Radiopharmaceutical Market CAGR of 8.7%, 2018 to 2023- Focusing on Top Companies like Bayer, Cardinal Health, General Electric Manufacturing Company (GEMAC), Siemens, General Electric & Trading Co LLC, Avid Radiopharmaceuticals and Lantheus Medical Imagin

Recently Added Detailed Market Report Studies The Global Radiopharmaceutical Market Examines The Performance, Status Size (Value & Volume), And Forecast, Categorizes The Healthcare Industry By Top Companies, Product Type, Key Regions, With Production, Consumption, Revenue (USD 10,473.88 million by 2023 from USD 5,841.22 million in 2016 and have a CAGR of 8.7% during the forecast period, 2017–2023) And Application.

Scope of the Report:

Radiopharmaceuticals are those radioisotopes when used for diagnosis or therapy; typically stimulate no physiological response from the patient. They are the unique medicinal formulations containing radioisotopes which can be used diagnosis and treatment of various chronic diseases. Radioisotopes play a very crucial part in the medical diagnostic procedures. In combination with imaging devices which record the gamma rays emitted from inside, healthcare professionals can study the dynamic processes taking place in various parts of the body.

Increasing prevalence of chronic diseases which indicates the growing need for early diagnosis and treatment is one of the major factors responsible for the growth of the market. Moreover, rising expenditure in oncology and growing emphasis on cancer management has also accelerated the market growth owing to the need for new diagnostic and treatment options for common as well as rare cancers.

The Leading Market Players In The Global Radiopharmaceutical Market Include

· Bayer AG,

· Cardinal Health Inc.,

· General Electric Company,

· Lantheus Medical Imaging, Inc.,

· Siemens,

· Avid Radiopharmaceuticals,

· IBA Dosimetry

· Others

For A Sample Copy of the Report or Any Further Inquiries @ https://www.researchformarkets.com/sample/global-radiopharmaceutical-market-221802

Both diagnostic & treatment characteristics of radiopharmaceutical driving the market growth. As per World Nuclear Association, in a quarter of the world population, about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this. Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs and used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells.

Increasing Prevalence of Chronic Diseases is also driving the growth of the market. According to the World Cancer Research Fund International, in 2015, cancer was responsible for 8.8 million deaths and is the second leading cause of death across the globe. As per the American Heart Association, in 2017, about 92.1 million Americans were diagnosed with cardiovascular disease. Additionally, as per the National Research University Higher School of Economics, tension-type headaches (about 1,500 million cases), migraine (about 1,000 million), medication overuse headaches (about 60 million), and Alzheimer's disease and other dementias (about 46 million cases) are the most common type of neurological disorders in 2015.

Whereas certain factors such as the high cost of radiopharmaceuticals is restraining the growth of the market. As per National Research Universal (NRU), the cost of some nuclear medicine have increased by as much as 1,000 percent recently. Similarly, according to the research, the overall financial cost for the underutilized radiopharmaceutical materials due to canceled and rescheduled procedures for 142 patients was about 39,760 US dollar. The daily financial loss from these cancellations was between USD 560 to USD 1120

Request for Report Brochure for Latest Industry Insights @ https://www.researchformarkets.com/reports/global-radiopharmaceutical-market-221802

On the basis of type, the market for Radiopharmaceutical is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals By type, the market for diagnostic type radiopharmaceuticals accounted for the largest market share in 2017.

On the basis of type of tests, the market for Radiopharmaceutical is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan and others. By type of tests, the market for intermediate Radiopharmaceutical accounted for the largest market share in 2017.

The global Radiopharmaceutical, by application, is segmented into oncology, cardiology, neurology, urology, and others. By application, the market for Oncology accounted for the largest market share in 2017.

The global Radiopharmaceutical, by route of administration, is segmented into oral, intravenous and other route of administration. The intravenous segment holds the largest market share in global Radiopharmaceutical, by route of administration.

On the basis of the route of administration, the global Radiopharmaceutical market is segmented into intravenous, intravitreal, and others. The intravitreal segment dominates the global Radiopharmaceutical market.

The global Radiopharmaceutical, on the basis of end-user, is segmented into hospitals, diagnostic centers, research institutes and others. Hospitals hold the largest market share in the global Radiopharmaceutical market.

Major TOC of Global Biosensor Market Research Report

1 Report Prologue

2 Market Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Radiopharmaceutical Market, by Type

8 Global Radiopharmaceutical Market, by Region

9 Company Landscape

10 Company Profiles

11 MRFR Conclusion

12 Appendix

Get Attractive Discount @ https://www.researchformarkets.com/discount/global-radiopharmaceutical-market-221802

Study Objectives

• To provide historical and forecast revenue of the market segments and sub-segments with respect to – regional markets and their countries

• To provide insights into factors influencing and affecting the market growth

• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

• To provide economic factors that influence the global Radiopharmaceutical market

Target Audience

• Pharmaceutical and Medical Device Industries

• Potential Investors

• Medical Research Institutes

• Key Executive (CEO and COO) and Strategy Growth Manager

• Research Companies

Inquiry Before Buying@ https://www.researchformarkets.com/inquiry/global-radiopharmaceutical-market-221802

About Research for Markets:

Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.

Contact:

Mr. A Naidu

Research for Markets

Tel: +44 8000-4182-37 (UK)

Email: alan.naidu@researchformarkets.com

This release was published on openPR.